Knowing that the combination of angiotensin-converting enzyme inhibitors and calcium channel blockers is used for pulmonary hypertension in critical settings and that some of these drugs independently were therapeutically relevant in COVID-2019, the AI plataform BIOiSIM was used to conducted a in silico modelling, with some of these drugs. Here, ACE is linked to pulmonary hypertension.